Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

A mutation in the HR gene causes a rare form of irreversible hair loss in two Kashmiri families. Whole exome sequencing is effective for finding such mutations.

The study helps doctors use patient images to understand and apply SALT scores for treating severe alopecia areata.

CLEC4D gene variants may increase the risk of alopecia areata in Jordanians.

Patients with rheumatoid arthritis using tofacitinib had more serious side effects than those with alopecia areata.

People with autism are more likely to develop alopecia areata than those without autism.

An 11-year-old girl with a rare skin disorder also had cornea issues and dry eye, needing careful management.

AGD1 is important for root hair development in Arabidopsis, working with phosphoinositide signaling and the actin cytoskeleton.

Baricitinib effectively improves symptoms of atopic dermatitis and alopecia areata with few side effects.

New drugs, baricitinib and ritlecitinib, are effective for severe alopecia areata.

Ebastine may help regrow hair in alopecia areata patients.

The formula significantly boosts hair growth and density.

Patients with both connective tissue disease and acid reflux are more likely to have certain symptoms and physical signs.

The document's content couldn't be processed for a summary.

Patients with alopecia areata feel less regret about treatment decisions when they are involved in the decision-making process.

Two rare genetic diseases cause severe rickets in children due to defects in vitamin D metabolism.

Fexofenadine reduces discomfort but doesn't significantly improve hair regrowth in Alopecia Areata treatment.

Allergies, especially both seasonal and food, increase the risk of developing alopecia areata.

Some types of hair loss can continue for a long time after recovering from a severe drug reaction known as DRESS.

The document cannot be understood or processed.

Acitretin may cause salivary gland inflammation.

A new tool simplifies alopecia areata severity scoring but needs validation.

Ritlecitinib is the first FDA-approved pill for treating significant hair loss in alopecia areata patients aged 12 and up.

JAK inhibitors effectively regrow hair in children with alopecia areata and are safe to use.

Ritlecitinib improves hair regrowth in alopecia areata without increasing adverse risks.

Baricitinib shows promise in treating severe hair loss.

The document corrects errors in previous articles, including a reversed term, updated subject weights, hair count data, and reference numbering.

AcD scaffolds improve tissue repair and regeneration by combining stem cells with a supportive matrix.

Ritlecitinib can reduce inflammation and help hair regrow in Alopecia Areata.

Baricitinib improves alopecia areata and may help psoriasis but might not be ideal for psoriatic arthritis.

Baricitinib effectively promotes hair regrowth and improves well-being in severe alopecia areata patients.